Research Papers

25 of 4933 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer.
Okazawa Y; Kamigaki T; Sugimoto K; Yamada T; Yoshida Y; Okada S; Ibe H; Oguma E; Iwai T; Matsuda A; Yamada T; Hasegawa S; Goto S; Takimoto R; Sakamoto K.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Integrated analysis and validation reveal CYTH4 as a potential prognostic biomarker in acute myeloid leukemia.
Wang H; Xiao Y; Zhou W; Li Y.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer.
Dorjkhorloo G; Erkhem-Ochir B; Shiraishi T; Sohda M; Okami H; Yamaguchi A; Shioi I; Komine C; Nakazawa N; Ozawa N; Shibasaki Y; Okada T; Osone K; Sano A; Sakai M; Ogawa H; Yokobori T; Shirabe K; Saeki H.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
RNF125‑mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells.
Feng X; Song D; Liu X; Liang Y; Jiang P; Wu S; Liu F.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Heparanase inhibitor OGT 2115 induces prostate cancer cell apoptosis via the downregulation of MCL‑1.
Li X; Xu SJ; Jin B; Lu HS; Zhao SK; Ding XF; Xu LL; Li HJ; Liu SC; Chen J; Chen G.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Cross‑talk between lymphangiogenesis and malignant melanoma cells: New opinions on tumour drainage and immunization (Re…
Ju W; Cai HH; Zheng W; Li DM; Zhang W; Yang XH; Yan ZX.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human or…
Todoroki K; Abe Y; Matsuo K; Nomura H; Kawahara A; Nakamura Y; Nakamura M; Seki N; Kusukawa J.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Identification and validation of prognostic genes and immune landscape signatures based on a fatty acid oxidation‑relat…
Guo F; Ling G; Zhai Z; Lei Y; Mo L; Piao H.
Oncol Lett (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A pilot study to evaluate the expression of microRNA‑let‑7a in patients with intestinal‑type sinonasal adenocarcinoma.
Gioacchini FM; Di Stadio A; De Luca P; Camaioni A; Pace A; Iannella G; Rubini C; Santarelli M; Tomassetti M; Scarpa A; Olivieri F; Re M.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Regulation of the migration of colorectal cancer stem cells via the TLR4/MyD88 signaling pathway by the novel surface m…
Li Y; Shi J; Liu Z; Lin Y; Xie A; Sun W; Liu J; Liang J.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multi‑dimensional analysis reveals NCKAP5L is a promising biomarker for the diagnosis and prognosis of human cancers, e…
Sha Y; Liang W; Mo C; Hou X; Ou M.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia.
Tsotridou E; Georgiou E; Tragiannidis A; Avgeros C; Tzimagiorgis G; Lambrou M; Papakonstantinou E; Galli-Tsinopoulou A; Hatzipantelis E.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Update on clinical characteristics and molecular insights for uterine intravenous leiomyomatosis (Review).
Zhou X; Qi X; Zhao X; Yang F.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression o…
Yang Y; Du J; Huang YF; He W; Liu L; Li D; Chen R.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study.
Ishioka Y; Tanaka H; Makiguchi T; Fujishima S; Nunomura Y; Sakamoto H; Shiratori T; Taima K; Tasaka S.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dietary and supplementary vitamin C intake and the risk of lung cancer: A meta‑analysis of cohort studies.
Tran DV; Luu XQ; Tran HTT; Myung SK.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer.
Saeki H; Horimoto Y; Hlaing MT; Men Y; Rong L; Ishizuka Y; Uomori T; Yoshida E; Terao Y; Arakawa A; Saito T; Yao T.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combinati…
López-Méndez JA; Ventura-Gallegos JL; Camacho-Arroyo I; Lizano M; Cabrera-Quintero AJ; Romero-Córdoba SL; Martínez-Vázquez M; Jacobo-Herrera NJ; León-Del-Río A; Paredes-Villa AA; Zentella-Dehesa A.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration a…
Ding Y; Wang H; Cao W; Cao T; Jiang H; Yu Z; Zhou Y; Xu M.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Selection of breast cancer subtypes to improve benefits of intensive dose‑dense chemotherapy: A systematic meta‑analysi…
Su D; Zhang T; Huang H; Su X; Li Y; Wei X; Zhang Y.
Oncol Lett (Unknown)
Published: 2023
5/6 Transparent
Data Registered Funding Declared
Interaction between miR‑206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma.
Wang J; Yao G; Zhang B; Zhao Z; Fan Y.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination o…
Nakayama T; Saito R; Furuya S; Shoda K; Maruyma S; Takiguchi K; Shiraishi K; Akaike H; Kawaguchi Y; Amemiya H; Kawaida H; Tsukiji N; Shirai T; Shinmori H; Yamamoto M; Nomura S; Tsukamoto T; Suzuki-Inoue K; Ichikawa D.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of traditional Chinese medicine nursing intervention in postoperative patients after gastrectomy.
Fan L; He Y; Li Y; Li X; Liu D; Wang R.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Influence of tumor mycobiome on cancer pathogenesis (Review).
Liu W; Li Z; Li X; Cao H; Jiang H; Niu Q; Hu B.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types o…
Abbas M; Heitplatz B; Bernemann C; Boegemann M; Trautmann M; Schrader AJ; Wardelmann E; Schlack K.
Oncol Lett (Unknown)
Published: 2023
3/6 Transparent
Funding Declared